The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis
Open accessAbstract
Alcohol misuse is the leading cause of cirrhosis and the second most common indication for liver transplantation in the Western world. We performed a genome-wide association study for alcohol-related cirrhosis in individuals of European descent (712 cases and 1,426 controls) with subsequent validation in two independent European cohorts (1,148 cases and 922 controls). We identified variants in the MBOAT7 (P = 1.03 × 10(-9)) and TM6SF2 (P = 7.89 × 10(-10)) genes as new risk loci and confirmed rs738409 in PNPLA3 as an important risk locus for alcohol-related cirrhosis (P = 1.54 × 10(-48)) at a genome-wide level of significance. These three loci have a role in lipid processing, suggesting that lipid turnover is important in the pathogenesis of alcohol-related cirrhosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Membrane-bound O-acyltransferase 7 (Mboat7) encodes a phospholipid synthetic enzyme identified through GWAS7,8.”
From Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease (2023) · cites this paper as [7]
In the citing paper
“Additionally, after the initial discovery of Membrane Bound O-Acyltransferase Domain Containing 7 (MBOAT7) as a risk gene for alcohol-related cirrhosis, MBOAT7 allele rs641738 was subsequently verified as a risk factor for MASH (137-139).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [137]
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Howie, B. N., Donnelly, P., & Marchini, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000529 · Cited by 3,928
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
LocusZoom: regional visualization of genome-wide association scan results
Pruim, R. J., Welch, R. P., Sanna, S., Teslovich, T. M., Chines, P. S., Gliedt, T. P., Boehnke, M., Abecasis, G. R., & Willer, C. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq419 · Cited by 2,707
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
study, F. T. D., Daly, A. K., Donaldson, P. T., Bhatnagar, P., Shen, Y., Pe’er, I., Floratos, A., Daly, M. J., Goldstein, D. B., John, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.379 · Cited by 1,051
Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Global burden of alcoholic liver diseases
Rehm, J., Samokhvalov, A. V., & Shield, K. D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.007 · Cited by 740
Research works printed but not linked: 1
- Treutlein, J. et al. Genome-wide association study of alcohol dependence. Arch. Gen. Psychiatry 66, 773–784 (2009). · DOI
Cited by
Sorted by citations
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
FinnGen provides genetic insights from a well-phenotyped isolated population
Kurki, M. I., Karjalainen, J., Palta, P., Sipilä, T. P., Kristiansson, K., Donner, K. M., Reeve, M. P., Laivuori, H., Aavikko, M., Kaunisto, M. A., et al. (2023) · Nature · doi:10.1038/s41586-022-05473-8 · Cited by 4,233
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Crabb, D. W., Im, G. Y., Szabó, G., Mellinger, J. L., & Lucey, M. R. (2019) · Hepatology · doi:10.1002/hep.30866 · Cited by 938
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Eslam, M., Valenti, L., & Romeo, S. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.003 · Cited by 971
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
Abul-Husn, N. S., Cheng, X., Li, A. H., Xin, Y., Schurmann, C., Stevis, P., Liu, Y., Kozlitina, J., Stender, S., Wood, G. C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712191 · Cited by 827
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745
“This polymorphism is also associated with fibrosis in alcoholic liver disease (Buch et al., 2015) and chronic hepatitis C (Thabet et al., 2016), suggesting that this pathway could contain therapeutic targets for several liver diseases.”
Mancina, R. M., Dongiovanni, P., Petta, S., Pingitore, P., Meroni, M., Rametta, R., Borén, J., Montalcini, T., Pujia, A., Wiklund, O., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.032 · Cited by 676
Lipid droplets and liver disease: from basic biology to clinical implications
Gluchowski, N. L., Becuwe, M., Walther, T. C., & Farese, R. V. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.32 · Cited by 690
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Toh, M. R., Wong, E. Y. T., Wong, S. H., Ng, A. W. T., Loo, L., Chow, P. K.-H., & Ngeow, J. Y. Y. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.01.033 · Cited by 622
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Huang, D. Q., Mathurin, P., Cortez-Pinto, H., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00688-6 · Cited by 553
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Update on NAFLD genetics: From new variants to the clinic
Trépo, E., & Valenti, L. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.020 · Cited by 393
Self-citationKurki, M., Karjalainen, J. M., Palta, P., Sipila, T. P., Kristiansson, K., Donner, K. M., Reeve, M. P., Laivuori, H. M., Aavikko, M., Kaunisto, M. A., et al. (2022) · medRxiv · doi:10.1101/2022.03.03.22271360 · Cited by 405
Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review
Singal, A. K., & Mathurin, P. (2021) · JAMA · doi:10.1001/jama.2021.7683 · Cited by 398
Fang, Y., Chen, H., Wang, C., & Liang, L. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i27.2974 · Cited by 407
Dongiovanni, P., Stender, S., Pietrelli, A., Mancina, R. M., Cespiati, A., Petta, S., Pelusi, S., Pingitore, P., Badiali, S., Maggioni, M., et al. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12719 · Cited by 367
Alcohol-associated liver disease
Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176345 · Cited by 359
Changing epidemiology of hepatocellular carcinoma in Asia
Zhang, C., Cheng, Y., Zhang, S., Fan, J., & Gao, Q. (2022) · Liver International · doi:10.1111/liv.15251 · Cited by 349
Fibrosis and alcohol-related liver disease
Lackner, C., & TINIAKOS, D. G. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.003 · Cited by 326
Alcohol effects on hepatic lipid metabolism
Jeon, S., & Carr, R. (2020) · Journal of Lipid Research · doi:10.1194/jlr.r119000547 · Cited by 326
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Tacke, F., Puengel, T., Loomba, R., & Friedman, S. L. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.038 · Cited by 321
Ma, Y., Belyaeva, O. V., Brown, P. M., Fujita, K., Valles, K., Karki, S., de Boer, Y. S., Koh, C., Chen, Y., Du, X., et al. (2018) · Hepatology · doi:10.1002/hep.30350 · Cited by 317
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
Eslam, M., & George, J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0212-0 · Cited by 315
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
Juanola, O., Martínez‐López, S., Francés, R., & Gómez‐Hurtado, I. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18105227 · Cited by 330
Metabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki‐Järvinen, H., & Loomba, R. S. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 365
ACG Clinical Guideline: Alcohol-Associated Liver Disease
Jophlin, L., Singal, A. K., Bataller, R. A., Wong, R. J., Sauer, B. G., Terrault, N. A., & Shah, V. H. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002572 · Cited by 319
Trépo, E., Romeo, S., Zucman‐Rossi, J., & Nahon, P. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.011 · Cited by 299
Self-citationAccumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
BasuRay, S., Wang, Y., Šmagris, Ē., Cohen, J. C., & Hobbs, H. H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901974116 · Cited by 284
Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning
Liu, Y., Basty, N., Whitcher, B. J., Bell, J. D., Sorokin, E. P., van Bruggen, N., Thomas, E. L., & Cule, M. (2021) · eLife · doi:10.7554/elife.65554 · Cited by 270
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
Donati, B., Dongiovanni, P., Romeo, S., Meroni, M., McCain, M., Miele, L., Petta, S., Maier, S., Rosso, C., Luca, L. D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04991-0 · Cited by 257
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
Anstee, Q. M., Seth, D., & Day, C. P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.037 · Cited by 254
Pathophysiology and Management of Alcoholic Liver Disease: Update 2016
Stickel, F., Datz, C., Hampe, J., & Bataller, R. A. (2017) · Gut and Liver · doi:10.5009/gnl16477 · Cited by 258
Self-citationSmagris, E., Gilyard, S., BasuRay, S., Cohen, J. C., & Hobbs, H. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719955 · Cited by 226
Impact of non-invasive biomarkers on hepatology practice: past, present and future
Anstee, Q. M., Castera, L., & Loomba, R. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.026 · Cited by 224
Krawczyk, M. J., Rau, M., Schattenberg, J. M., Bantel, H., Pathil, A., Demir, M., Kluwe, J., Boettler, T., Lammert, F., & Geier, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p067454 · Cited by 204
Self-citationLeveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Romeo, S., Sanyal, A. J., & Valenti, L. V. C. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.12.002 · Cited by 206
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207
Argemí, J., Latasa, M. U., Atkinson, S. R., Blokhin, I. O., Massey, V. L., Gue, J. P., Cabezas, J., Lozano, J. J., Booven, D. V., Bell, A. W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11004-3 · Cited by 195
Self-citationStaufer, K., Huber-Schönauer, U., Strebinger, G., Pimingstorfer, P., Suesse, S., Scherzer, T. M., Paulweber, B., Ferenci, P., Stimpfl, T., Yegles, M., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.04.040 · Cited by 190
Self-citationAlcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Liu, S.-Y., Tsai, I., & Hsu, Y.-C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105170 · Cited by 186
Alcoholic Liver Disease in Asia, Europe, and North America
Liangpunsakul, S., Haber, P., & McCaughan, G. W. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.043 · Cited by 181
Luukkonen, P. K., Zhou, Y., Hyötyläinen, T., Leivonen, M., Arola, J. T., Orho‐Melander, M., Orešič, M., & Yki‐Järvinen, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.045 · Cited by 178
Carlsson, B., Lindén, D., Brolén, G., Liljeblad, M., Bjursell, M., Romeo, S., & Loomba, R. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15738 · Cited by 169
The genetics of alcohol dependence and alcohol-related liver disease
Stickel, F., Moreno, C., Hampe, J., & Morgan, M. Y. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.011 · Cited by 165
Self-citationEmdin, C. A., Haas, M. E., Khera, A. V., Aragam, K. G., Chaffin, M. D., Klarin, D. M., Hindy, G., Jiang, L., Wei, W., Feng, Q., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008629 · Cited by 166
Global Epidemiology of Hepatocellular Carcinoma
Singh, S. P., Madke, T., & Chand, P. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.102446 · Cited by 178
Boyle, M., Masson, S., & Anstee, Q. M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.006 · Cited by 162
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
Genetic and epigenetic factors determining NAFLD risk
Jonas, W., & Schürmann, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101111 · Cited by 165
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis
Teo, K., Abeysekera, K. W. M., Adams, L. A., Aigner, E. S., Anstee, Q. M., Bañales, J. M., Banerjee, R., Basu, P., Berg, T., Bhatnagar, P., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.027 · Cited by 156
Self-citationGrimaudo, S., Pipitone, R. M., Pennisi, G., Celsa, C., Cammà, C., Marco, V. D., Barcellona, M. R., Boemi, R., Enea, M., Giannetti, A., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.08.011 · Cited by 152
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
Luo, F., Oldoni, F., & Das, A. (2021) · Hepatology Communications · doi:10.1002/hep4.1822 · Cited by 155
History of Nonalcoholic Fatty Liver Disease
Lonardo, A., Leoni, S., Alswat, K., & Fouad, Y. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165888 · Cited by 154
Kawaguchi, T., Shima, T., Mizuno, M., Mitsumoto, Y., Umemura, A., Kanbara, Y., Tanaka, S., Sumida, Y., Yasui, K., Takahashi, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0185490 · Cited by 142
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review
Ajmera, V. H., Terrault, N. A., & Harrison, S. A. (2017) · Hepatology · doi:10.1002/hep.29055 · Cited by 137
Strnad, P., Buch, S., Hamesch, K., Fischer, J., Rosendahl, J., Schmelz, R., Brueckner, S., Brosch, M., Heimes, C. V., Woditsch, V., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316228 · Cited by 137
Self-citationCherubini, A., Ostadreza, M., Jamialahmadi, O., Pelusi, S., Rrapaj, E., Casirati, E., Passignani, G., Norouziesfahani, M., Sinopoli, E., Baselli, G., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02553-8 · Cited by 136
Yang, J., Trépo, E., Nahon, P., Cao, Q., Moreno, C., Letouzé, É., Imbeaud, S., Gustot, T., Deviere, J. M. E., Debette, S., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31910 · Cited by 132
Self-citationHelsley, R. N., Varadharajan, V., Brown, A. L., Gromovsky, A. D., Schugar, R. C., Ramachandiran, I., Fung, K., Kabbany, M. N., Banerjee, R., Neumann, C. K. A., et al. (2019) · eLife · doi:10.7554/elife.49882 · Cited by 129
Thabet, K., Asimakopoulos, A., Shojaei, M., Romero‐Gómez, M., Mangia, A., Irving, W. L., Berg, T., Dore, G. J., Grønbæk, H., Sheridan, D. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms12757 · Cited by 130
Self-citationLiver Function and Risk of Type 2 Diabetes: Bidirectional Mendelian Randomization Study
Silva, N. M. G. D., Borges, M. C., Hingorani, A. D., Engmann, J., Shah, T., Zhang, X., Luan, J., Langenberg, C., Wong, A., Kuh, D. J., et al. (2019) · Diabetes · doi:10.2337/db18-1048 · Cited by 131
Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology
Sookoian, S. C., Pirola, C. J., Valenti, L. V. C., & Davidson, N. O. (2020) · Hepatology · doi:10.1002/hep.31229 · Cited by 130
Emdin, C. A., Haas, M., Ajmera, V. H., Simon, T. G., Homburger, J. R., Neben, C. L., Jiang, L., Wei, W., Feng, Q., Zhou, A. Y., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.12.011 · Cited by 131
Chen, V. L., Du, X., Chen, Y., Kuppa, A., Handelman, S. K., Vohnoutka, R. B., Peyser, P. A., Palmer, N. D., Bielak, L. F., Halligan, B. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20870-1 · Cited by 131
Alcoholic liver disease: A current molecular and clinical perspective
Ohashi, K., Pimienta, M., & Seki, E. (2018) · Liver Research · doi:10.1016/j.livres.2018.11.002 · Cited by 133
Schafmayer, C., Harrison, J., Buch, S., Lange, C., Reichert, M., Hofer, P., Cossais, F., Kupčinskas, J., Schönfels, W. V., Schniewind, B., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317619 · Cited by 130
Self-citationLoss of hepatic Mboat7 leads to liver fibrosis
Thangapandi, V. R., Knittelfelder, O., Brosch, M., Patsenker, E., Vvedenskaya, O., Buch, S., Hinz, S., Hendricks, A., Nati, M., Herrmann, A., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-320853 · Cited by 125
Self-citationValentine, W. J., Yanagida, K., Kawana, H., Kono, N., Noda, N. N., Aoki, J., & Shindou, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101470 · Cited by 127
Nutrition and Genetics in NAFLD: The Perfect Binomium
Meroni, M., Longo, M., Rustichelli, A., & Dongiovanni, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082986 · Cited by 125
Soto-Angona, Ó., Anmella, G., Valdés-Florido, M. J., De Uribe-Viloria, N., Carvalho, A. F., Penninx, B. W. J. H., & Berk, M. (2020) · BMC Medicine · doi:10.1186/s12916-020-01713-8 · Cited by 122
Arab, J. P., Roblero, J. P., Altamirano, J., Bessone, F., Araújo, R. C., la Tijera, F. H., Restrepo, J. C., Torre, A., Urzua, A. M., Simonetto, D. A., et al. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.04.005 · Cited by 126
Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes
Pazoki, R., Vujković, M., Elliott, J., Εvangelou, Ε., Gill, D., Ghanbari, M., van der Most, P. J., Pinto, R. C., Wielscher, M., Farlik, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22338-2 · Cited by 116
Stickel, F., Buch, S., Nischalke, H. D., Weiss, K. H., Gotthardt, D. N., Fischer, J., Rosendahl, J., Marot, A., Elamly, M., Casper, M., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0041-8 · Cited by 119
Self-citationNAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?
Stols‐Gonçalves, D., Hovingh, G. K., Nieuwdorp, M., & Holleboom, A. G. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.08.008 · Cited by 118
Machine learning enables new insights into genetic contributions to liver fat accumulation
Haas, M. E., Pirruccello, J. P., Friedman, S. N., Wang, M., Emdin, C. A., Ajmera, V. H., Simon, T. G., Homburger, J. R., Guo, X., Budoff, M., et al. (2021) · Cell Genomics · doi:10.1016/j.xgen.2021.100066 · Cited by 118
The role of PNPLA3 in health and disease
Pingitore, P., & Romeo, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.018 · Cited by 115
Longo, M., Meroni, M., Paolini, E., Erconi, V., Carli, F., Fortunato, F., Ronchi, D., Piciotti, R., Sabatini, S., Macchi, C., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.11.007 · Cited by 119
Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study
Thursz, M. R., Kamath, P. S., Mathurin, P., Szabó, G., & Shah, V. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.041 · Cited by 112
Stickel, F., Lutz, P. L., Buch, S., Nischalke, H. D., da Silva, I. P., Rausch, V., Fischer, J., Weiss, K. H., Gotthardt, D. N., Rosendahl, J., et al. (2019) · Hepatology · doi:10.1002/hep.30996 · Cited by 110
Self-citationToward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond
Krawczyk, M. J., Liebe, R., & Lammert, F. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.053 · Cited by 114
Self-citationMitsche, M. A., Hobbs, H. H., & Cohen, J. C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002333 · Cited by 108
Szabó, G., Kamath, P. S., Shah, V. H., Thursz, M. R., Mathurin, P., Addolorato, G., Bataller, R. A., Burra, P., Castéra, L., Cortez‐Pinto, H., et al. (2019) · Hepatology · doi:10.1002/hep.30369 · Cited by 108
Self-citationDiagnosis and management of secondary causes of steatohepatitis
Liebe, R., Esposito, I., Bock, H. H., Dahl, S. V., Stindt, J., Baumann, U., Luedde, T., & Keitel, V. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.045 · Cited by 114
Chen, V. L., Oliveri, A., Miller, M. J., Wijarnpreecha, K., Du, X., Chen, Y., Cushing, K. C., Lok, A. S., & Speliotes, E. K. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.01.040 · Cited by 108
Genetic and Epigenetic Modifiers of Alcoholic Liver Disease
Meroni, M., Longo, M., Rametta, R., & Dongiovanni, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123857 · Cited by 108
Yang, J., Trépo, E., Nahon, P., Cao, Q., Moreno, C., Letouzé, É., Imbeaud, S., Bayard, Q., Gustot, T., Deviere, J. M. E., et al. (2019) · Hepatology · doi:10.1002/hep.30623 · Cited by 107
Self-citationXian, Y., Weng, J., & Xu, F. L. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001263 · Cited by 111
Palma, R., Pronio, A., Romeo, M., Scognamiglio, F., Ventriglia, L., Ormando, V. M., Lamazza, A., Pontone, S., Federico, A., & Dallio, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133649 · Cited by 113
Cytosolic phospholipase A2 and lysophospholipid acyltransferases
Kita, Y., Shindou, H., & Shimizu, T. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.08.006 · Cited by 105
Trépo, E., Caruso, S., Yang, J., Imbeaud, S., Couchy, G., Bayard, Q., Letouzé, É., Ganne‐Carrié, N., Moreno, C., Oussalah, A., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00603-3 · Cited by 104
Self-citationSchwantes-An, T.-H. L., Darlay, R., Mathurin, P., Masson, S., Liangpunsakul, S., Mueller, S., Aithal, G. P., Eyer, F., Gleeson, D. C., Thompson, A., et al. (2020) · Hepatology · doi:10.1002/hep.31535 · Cited by 101
Self-citationIsraelsen, M. E., Juel, H. B., Detlefsen, S., Madsen, B. S., Rasmussen, D. N., Larsen, T. R., Kjærgaard, M., Jensen, M. J. F., Stender, S., Hansen, T. F., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.11.038 · Cited by 99
Microbiota, a key player in alcoholic liver disease
Cassard, A.-M., & Ciocan, D. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0067 · Cited by 100
Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
Luo, F., Šmagris, Ē., Martin, S. A., do Vale, G. D., McDonald, J. G., Fletcher, J. A., Burgess, S. C., Hobbs, H. H., & Cohen, J. C. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.12.008 · Cited by 97
Hydes, T., Alam, U., & Cuthbertson, D. J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.640557 · Cited by 105
Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice
Fan, Y., Lu, H., Guo, Y., Zhu, T., Garcia-Barrio, M. T., Jiang, Z., Willer, C. J., Zhang, J., & Chen, Y. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.005 · Cited by 92
Pathogenesis of Alcohol-Associated Liver Disease
Osna, N. A., Rasineni, K., Ganesan, M., Donohue, T. M., & Kharbanda, K. K. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.05.004 · Cited by 99
Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity
Caruso, S., O’Brien, D. R., Cleary, S. P., Roberts, L. R., & Zucman‐Rossi, J. (2020) · Hepatology · doi:10.1002/hep.31394 · Cited by 96
Metadata
- Authors
- Buch, S., Stickel, F., Trépo, E., Way, M., Herrmann, A., Nischalke, H. D., Brosch, M., Rosendahl, J., Berg, T., Ridinger, M., Rietschel, M., McQuillin, A., Frank, J., Kiefer, F., Schreiber, S., Lieb, W., Soyka, M., Semmo, N., Aigner, E., Datz, C., Schmelz, R., Brückner, S., Zeissig, S., Stephan, A.-M., Wodarz, N., Devière, J., Clumeck, N., Sarrazin, C., Lammert, F., Gustot, T., Deltenre, P., Völzke, H., Lerch, M. M., Mayerle, J., Eyer, F., Schafmayer, C., Cichon, S., Nöthen, M. M., Nothnagel, M., Ellinghaus, D., Huse, K., Franke, A., Zopf, S., Hellerbrand, C., Moreno, C., Franchimont, D., Morgan, M. Y., & Hampe, J.
- Affiliations
- University Hospital Carl Gustav Carus (DE)
- University Hospital Zurich (CH)
- Université Libre de Bruxelles (BE)
- The Royal Free Hospital (GB)
- University of Bonn (DE)
- University Hospital Leipzig (DE)
- Kanton Aargau (CH)
- Heidelberg University (DE)
- University College London (GB)
- University Hospital Schleswig-Holstein (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Ludwig-Maximilians-Universität München (DE)
- University Hospital of Bern (CH)
- University of Salzburg (AT)
- University of Regensburg (DE)
- University Hospital Frankfurt (DE)
- Universitätsklinikum des Saarlandes (DE)
- Universitätsmedizin Greifswald (DE)
- TUM Klinikum (DE)
- University Hospital of Basel (CH)
- University of Cologne (DE)
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
- Universitätsklinikum Erlangen (DE)
- University Hospital Regensburg (DE)
- Corresponding author
- Stickel, Felix
- ORCID
- Buch, Stephan
- Stickel, Felix
- Trépo, Eric
- Way, Michael
- Herrmann, Alexander
- Nischalke, Hans Dieter
- Brosch, Mario
- Rosendahl, Jonas
- Berg, Thomas
- Ridinger, Monika
- Rietschel, Marcella
- McQuillin, Andrew
- Frank, Josef
- Kiefer, Falk
- Schreiber, Stefan
- Lieb, Wolfgang
- Soyka, Michael
- Semmo, Nasser
- Aigner, Elmar
- Datz, Christian
- Schmelz, Renate
- Zeissig, Sebastian
- Wodarz, Norbert
- Lammert, Frank
- Gustot, Thierry
- Deltenre, Pierre
- Völzke, Henry
- Lerch, Markus M
- Mayerle, Julia
- Eyer, Florian
- Schafmayer, Clemens
- Cichon, Sven
- Nöthen, Markus M
- Nothnagel, Michael
- Ellinghaus, David
- Huse, Klaus
- Hellerbrand, Claus
- Moreno, Christophe
- Franchimont, Denis
- Morgan, Marsha Y
- Hampe, Jochen
- Venue
- Nature Genetics
- Published
- 2015-10-19
- Volume
- 47
- Issue
- 12
- Pages
- 1443-1448
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1830916533
- Cited by
- 565
- References
- 49
- Citations by year
- 2026: 30 · 2025: 38 · 2024: 51 · 2023: 72 · 2022: 54 · 2021: 69 · 2020: 82 · 2019: 57 · 2018: 44 · 2017: 43 · 2016: 21 · 2015: 2
- FWCI
- 29.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.zora.uzh.ch
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- IRIS (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Eye Institute (01EY1103)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- alcoholic cirrhosis, PNPLA3, MBOAT7, TM6SF2, genetic susceptibility loci, rs738409, lipid metabolism, alcohol abuse
- MeSH terms
- Acyltransferases, Adult, Aged, Female, Humans, Lipase, Liver Cirrhosis, Alcoholic, Male, Membrane Proteins, Middle Aged, Risk Factors, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Phospholipases A2, Calcium-Independent, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
